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Abstract.  The 67-kD elastin-binding protein (EBP) 
mediates cell adhesion to elastin and elastin fiber as- 
sembly, and it is similar, if not identical, to the 67-kD 
enzymatically inactive, alternatively spliced/~-galac- 
tosidase. The latter contains an elastin binding domain 
(S-GAL) homologous both to the aorta EBP and to 
NH2-terminal sequences of serine proteinases (Hinek, 
A., M. Rabinovitch, E  W. Keeley, and J. Callahan. 
1993. Z  Clin. Invest. 91:1198-1205).  We now confirm 
the functional importance of this homology by show- 
ing that elastolytic activity of a representative serine 
elastase, porcine pancreatic elastase, was prevented by 
an antibody (anti-S-GAL) and by competing with 
purified EBP or S-GAL peptide. Immunohistochemis- 
try of adult aorta indicates that the EBP exists as a 
permanent component of mature elastic fibers. This 
observation, together with the in vitro studies,  suggests 
that the EBP could protect insoluble elastin from ex- 
tracellular proteolysis and contribute to the extraordi- 
nary stability of this protein. Double immunolabeling 
of fetal lamb aorta with anti-S-GAL and antitropoelas- 
tin antibodies demonstrated, under light and electron 
microscopy, intracellular colocalization of the proteins 
in smooth muscle cells (SMC). Incubation of SMC 
with galactosugars to dissociate tropoelastin from EBP 
caused intraceUular aggregation of tropoelastin. A 
tropoelastin/EBP complex was extracted from SMC 
lysates by coimmunoprecipitation and cross-linking, 
and its functional significance was addressed by show- 
ing that its dissociation by galactosugars caused deg- 
radation of tropoelastin by endogenous serine protein- 
ase(s). This suggests that the EBP may also serve as a 
"companion" to intracellular tropoelastin, protecting 
this highly hydrophobic protein from self-aggregation 
and proteolytic degradation. 
T 
HE extracellular assembly of tropoelastin  into mature 
elastic  fibers  on the microfibrillar  scaffold is medi- 
ated by a cell surface 67-kD elastin-binding  protein 
(EBP) ~  that binds the VGVAPG hydrophobic repeat on tro- 
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1. Abbreviations used in this paper:  anti-C-GAL, polyclonal antibody to 
synthetic peptide reflecting a carboxy-terminal sequence of human/~-galac- 
tosidase; anti-C-term, polyclonal antibody to carboxy-terminal sequence of 
tropoelastin;  anti-S-GAL, polyclonal antibody to the synthetic poptide re- 
fleeting an elastin-hinding domain on alternatively spliced form of human 
~-galactosidase;  BA-4, monoclonal antibody to VGVAPG hydrophobic se- 
quence on elastin representing the elastin-hinding protein-binding  domain; 
BCZ, antibody to 67-kD elastin-binding protein isolated from bovine ciliary 
zonule; C-GAL, synthetic peptide PPQKNKDSWLDHV corresponding to 
the COOH-terminal  sequence common for both alternatively spliced forms 
of human  /~-GAL; DTSSP, dithio-bis-sulfosuccininfidylpropionate;  EBP, 
elastin-binding  protein;  GAM, goat anti-mouse; CZAR, goat anti-rabbit; 
H1-20, monoclonal antibody to tropoelastin; Hsp, heat shock protein; HLE, 
human leukocyte elastase; PPE, porcine pancreatic elastase; PVDF, poly- 
vinyldifluorida;  S-GAL,  synthetic peptides  WGSPSAQDEASPL corre- 
sponding to a sequence of alternatively spliced form of human/3-GAL con- 
taining  EBP; SMC, smooth muscle ceils. 
poelastin,  the cell membrane, and galactosugars  via three 
separate sites  (Hinek et al.,  1988; Mecharn et al.,  1989, 
1991). The coordinated release of both tropoelastin  and the 
EBP from the cell surface under the influence of galacto- 
sugars was discovered to be the central mechanism regulat- 
ing the extracellular assembly of elastic fibers (Hinek et al., 
1988, 1991). We have recently established  that the 67-kD 
EBP expressed by sheep aorta smooth muscle cells (SMC), 
which also binds laminin, demonstrates immunological and 
functional similarity, as well as sequence  homology, and may 
be identical  to the 67-kD, catalytically inactive variant  of 
human  ~-galactosidase  produced by  alternative  splicing 
(Morreau et al.,  1988). We further showed that the WG- 
SPSAQDEASPL domain, corresponding to a frame-shift- 
generated sequence unique to the alternatively spliced variant 
(S-GAL), is responsible for its elastin/laminin binding prop- 
erties (Hinek et al., 1993). In addition,  sequence homology 
among this domain and NH2-terminal sequences of several 
serine elastases  indicated that these proteins might share a 
common ligand-binding motif (Table I). Since electron mi- 
croscopic analysis  of immunogold labeling  localized  the 
EBP to mature elastic fibers (Hinek et al., 1993), we hypoth- 
esized that this protein, which mediates the proper extracel- 
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Serine Proteinases 
Proteins  Sequences 
Human S-GAL 
Sheep EBP 
Porcine pancreatic elastase 
Human prekallikrein 
Human plasminognn 







Comparison  of the unique elastin binding sequence  from the spliced variant of 
human/~-galactosidase  (Morreau et al.,  1989) with the sequence determined 
for CNBr fragment  of purified sheep elastin EBP (Hinek et al., 1993). 7 of 14 
residues are identical, and a further three substitutions  have no effect on net 
charge. NH2-terminal sequences of porcine pancreatic elastase and human 
prekallikrein,  human plasminogen,  and buman Factor IX are also included for 
comparison (Shotton and Hartley, 1970; Doolittle and Feng, 1987). Regions 
of sequence identity between these proteins are underlined. 
lular assembly of insoluble elastin, may also protect it by 
competing with extracellular serine proteinases,  Moreover, 
preliminary immunohistochemical colocalization of the EBP 
and  tropoelastin  in  intracellular  compartments  of  aortic 
SMC allowed us to speculate that the EBP might bind to tro- 
poelastin intracellularly (Hinek and Mecham, 1990). To fur- 
ther investigate the close relationship between these two pro- 
teins and, particularly, to establish whether the EBP might 
protect soluble tropoelastin and its insoluble polymer from 
degradation by serine proteinases, we developed the neces- 
sary reagents: a synthetic peptide reflecting the elastin bind- 
ing motif (S-GAL) and an antibody raised to this sequence 
(anti-S-GAL). 
In this  report,  we  first showed  in an in vitro assay that 
anti-S-GAL binds to porcine pancreatic elastase and, pre- 
sumably, by occupying the NH2-terminal of this representa- 
tive serine elastase, prevented its association with elastin and 
precluded its elastolytic activity as judged by degradation of 
an  [3H]elastin  substrate.  Conversely,  blocking  the  EBP- 
binding domain on elastin by a monoclonal antibody to the 
VGVAPG hydrophobic sequence also prevented the elasto- 
lyric  activity  of  PPE,  as  did  preincubation  of  insoluble 
[3H]elastin with purified EBP or with S-GAL peptides.  We 
next  used  immunogold labeling of fetal  sheep  aorta  and 
confirmed coimmunolocalization of the EBP and insoluble 
elastin over elastic  fibers.  Moreover,  double  immunogold 
labeling, as well as immunofluoreseence, showed intracellu- 
lar  colocalization of these  two  proteins  in cultured aortic 
SMC,  which actively synthesize elastin. Further biochemi- 
cal studies were then carried out to show that the newly syn- 
thesized EBP and tropoelastin coimmunoprecipitated as a 
complex  from  lysates of metabolically labeled SMC,  and 
that an excess of galactosugars that can dissociate this com- 
plex (Hinek et al.,  1989,  1991) caused aggregation of intra- 
cellular tropoelastin and also resulted in its degradation by 
endogenous serine proteinases. Together, our morphological 
and biochemical data indicate that the EBP may serve as a 
protective  companion  protein  for  tropoelastin  during  its 
secretion and extracellular assembly and may also protect 
the longevity of insoluble elastin. 
Materials and Methods 
Materials 
Chemicals  and  reagents were obtained  as  follows: bovine ligamentum 
nuchae insoluble elastin,  bovine tropoelastin,  r-elastin,  ~-elasfin, BA-4 
monoclonal antibody to the VGVAPG  sequence on the tropoelastin mole- 
cuie (Wrenn et al., 1986), and monospecific polyclonal antibody to bovine 
tropoelastin (Prosser et al., 1991) were purchased from Elasfin Products 
(Pacific, MO). Porcine pancreatic elastase, glucosamine, galactosamine, 
lactose, proteinase inhibitors, protein A-Sepharose, and all reagent grade 
chemicals were purchased from Sigma Imraunochamicals (St. Louis, MO). 
Media, fetal bovine serum, and other tissue culture reagents were obtained 
from Gibco Laboratories (Burlington, Ontario, Canada). All SDS-PAGE 
reagents were purchased from Bio-Rad Laboratories (Richmond, CA). The 
chemical cross-linker 3,3' dithio-bis-sulfosuccinimidylpropionate  (DTSSP) 
was purchased from Pierce Chemical Co. (Rockford, IL). The Immobiloa 
P transfer membranes were supplied by Millipore Ltd. (Mississauga, On- 
tario, Canada). The N-acetyI-VVGSPSAQDEASPL  oligopeptide (S-GAL), 
conesponding to the elastin binding domain of the alternatively spliced 
form  of  human  /3-galactosidase,  and  N-Ac-(C)PPQKNKDSWLDHV 
oligopeptide (C-GAL), corresponding to the COOH-terminal sequence of 
jS-galactosidase, were synthesized using an automated oligopeptide syn- 
thesizer (BioLynx; Pharmacia, Uppsala, Sweden). Polyclonal antibodies to 
these peptides and the polyclonal antibody to human/3-galactosidase were 
gifts from Dr. John Cailahan (University of Toronto). The H1-20 monoclo- 
hal antibody was raised to 52-kD truncated tropoelasfin isolated from ovine 
ductus arteriosus (Hinek and Rabinovitch, 1992). The BCZ monoclonal an- 
tibody to the bovine 67-kD elastin-binding protein (Mecham et al., 1988) 
was a gift from Dr. R. P. Mecham (Washington University, St. Louis, MO). 
The specific polyclonal antibody raised against a synthetic peptide rep- 
resenting the carboxy-terminal sequence of tropoelastin encoded by exon 
36 (Rosenbloom et al., 1986) was kindly supplied by Dr. J. Rasenbloom 
(University of Pennsylvania, Philadelphia, PA). Species and type-specific 
secondary antibodies, goat anti-rabbit  (GAR), and goat anti-mouse  (GAM) 
conjugated with gold particles for EM immunolocaliT~tion  were obtained 
from Janssen Life Science Products (Piscataway, NJ). HRP-conjugated sec- 
ondary  antibodies  used  in Western immunoblotting  were  supplied by 
Boehdnger Maanheim Corp.  (Indianapolis, IN). FITC-conjugated GAM 
and  GAIt  secondary  antibodies  were  obtained  from  ICN  Immuno- 
Biologicals (Lisle, IL).  The Afli-gel 10 and polyvinyldifluoride (PVDF) 
membranes were from Bio-Rad Laboratories. The enhanced chemilumines- 
cence Western blotting detection kit was from Amersham Canada Ltd. 
(OakviUe, Ontario, Canada). The [3H]elastin substrate was prepared ac- 
cording to the methods used by Takahashi et al. 0973) to radidlabel insolu- 
ble elastin. Radioactive [3H]NaBIG, [3H]serine, [3H]valine, and [l~C]va- 
line were supplied by New England Nuclear (Boston, MA). 
Interactions between l~I-I]Elastin, Pancreatic Elastase, 
and the EBP 
PPE is a serine proteinase in which the NH2-terminal sequence displays 
the strongest homology with the elastin-binding domain of the EBP (Table 
I). In an attempt to test the functional significance of this sequence homol- 
ogy, we investigated whether an antibody (anti-S-GAL) raised to the elastin 
binding domain of the  EBP may block or modify the putative elastin- 
binding sequence present at the NH2-terminal of PPE.  We first showed, 
however, that anti-S-GAL  does indeed bind to PPE and does not react with 
the elastin substrate. Since the BA-4  antibody recognizing the receptor bind- 
ing domain on elastin was also used in further experiments, specificity of 
this antibody was also tested by confirming that it binds to elastins and not 
to elastases. 
The relative specificities of both anti-S-GAL and BA-4 antibodies was 
tested first by dot blot analysis and then by affinity chromatography. 200-/~g 
samples of PPE, human leukocyte elastase (HLE), ~-elastin, and c~*elastin 
were dot blotted on PVDF membranes and incubated with either anti-S- 
GAL or with BA-4 antibodies (2 mg/ml diluted 1:100). The blots were then 
visualized with appropriate HRP-conjugated secondary antibodies. 
Interactions between PPE and the above-mentioned antibodies were also 
tested in an additional experiment in which 2-rag samples of both anti-S- 
GAL and BA-.4  antibodies were immob'dized in triplicate on Afli-gel 10 as 
described previously (Hinek et al., 1991) and incubated for I h on ice with 
100-ng aliquots of PPE dissolved in 50 mM Tris-HC1 buffer. The affinity 
resins were then spun  down, and the elastolytic activity of supernatants con- 
taining the unbound enzyme was assessed. Elastolytic activity of PPE was 
assessed  in an  in vitro  assay  measuring  degradation  of an  insoluble 
[3H]elastin substrate as previously described (Leake et al., 1983; Banda 
and Werb, 1991). To eliminate possible residues of the EBP that might exist 
in the elastin preparation, the insoluble elastin used in all assays was ex- 
tracted with 2 M sodium chloride and 0.2 M lactose before being labeled 
with tritium. 
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NH2-terminal of PPE, 50-ng samples of this enzyme were dissolved in 200 
/~1 of assay buffer (50 mM Tris-HC1, pH 8, containing 150 mM NaCI,  10 
mM CaCI2, 0.02% Brij, and 0.02%  sodium azide) and preincubated in an 
Eppendorf vial for  1 h  with different  concentrations of an anti-S-CAL 
(1 ng-100 ~g) or with 10 ~g of preimmune rabbit immunoglohulin. For 
comparison, PPE was also preincubated with 10 t~g of IgG from an antibody 
raised to synthetic peptides reflecting  the COOH-terminal of ~-galactosi- 
dase (anti-C-GAL). At the end of a 1-h preincubation, 200-/~g aliqnots of 
[SH]elastin substrate (specific activityq200 cpm/1 ~g) were added to each 
vial, and samples were incubated at 37°C for 6 h. At the end of the incuba- 
tion, all samples were microcentrifuged (8,000 g for 4 rain), and 100-t~l  ali- 
quots of supernatant containing the sohibilized degradation products were 
mixed with 4 ml scintillation  fluid and counted in triplicates in a liquid scin- 
tillation counter (Rackbeta model 1219; LKB Wallac, San Francisco, CA). 
We also assessed the effect of blocking the hydrophobic domains on 
elastin that are responsible for binding to the EBP (Senior et al., 1984; Hi- 
nek et al.,  1988; Mecham et al., 1989) and, presumably,  also to elastases 
sharing NH2-terminal  sequences homologous to the EBP (Hinek et al., 
1993). 200-ttg aliquots of [3H]elastin substrate suspended in 200/~1 of as- 
say buffer were preincubated for I h with 0.01-10 ~g of IgG fraction isolated 
from a  monoclonal antibody raised to the VGVAPG domain of elastin 
(Wrenn et al.,  1986;  Wrenn and Mecham,  1987).  For comparison, the 
[3H]elastin substrate was also incubated with 10/~g IgG from an antibody 
raised against a synthetic peptide representing the sequence at the COOH- 
terminus of tropoelastin, which does not bind the EBP (Rosenbloom et al., 
1986), and with 10 ~tg of normal mouse IgG. In an additional control experi- 
ment, the 200-/~g samples of [3H]elastin were also preincubated with 10 t~g 
of anti-S-CAL IgG. The substrate was then washed with TBS buffer before 
PPE addition. After a 1-h preincubation, all samples were mixed with 50-ng 
aliquots  of PPE dissolved in 200 ttl of assay buffer and incubated for 6 h 
at 37"C. 
To determine directly whether the EBP may also protect elastin, in sepa- 
rate experiments,  200-ttg samples of [31-1]elastin  substrate suspended in as- 
say buffer were preincubated for 1 h with 50 ~g of S-GAL synthetic peptide 
or with 50 ttg of purified EBP in the presence or absence of 100 mM lactose 
before a 6-h incubation with 50-ng aliquots of PPE. As controls, the radio- 
active elastin substrate was also preincubated with 100 mM lactose or with 
50 t~g of C-CAL or 10 ttg S-GAL synthetic peptides. 
In all studies involving comparison of different treatments, the radioac- 
tivity (epm/sample) released into the supernatant reflecting the degradation 
of [3H]elastin was assessed as described above, and the mean and standard 
deviations were calculated  from triplicate assessments from three different 
experiments.  The data were compared by ANOVA, and a Duncan test of 
multiple comparison was  used to  establish which of the  groups  were 
signiticanfly  different.  Results in the graphs are expressed  as percentages 
of control samples, reflecting values for degradation of radioactive elastin 
by PPE. 
lmmunoelectron Microscopy 
For immunoelectron  microscopy, a postembedding method was used (Hinek 
et al., 1991). Thin sections of fetal and adult ovine aorta, as well as adult 
ovine auricular cartilage and cultured fetal lamb aorta SMC,  were placed 
on nickel grids and blocked with 1% BSA, 1% normal goat serum, and 0.5 % 
Tween-20 in TBS. Extracellular elastin and intracellular tropoelastin were 
detected with H1-20, a  monoclonal antibody to tropoelastin (Hinek and 
Ra_.binoviteh, 1993), while the EBP present in the extracelhilar matrix and 
in intracellular compartments was detected with anti-S-GAL, an aflinity- 
purified polyelonal  antibody to the elastin/laminin-binding  domain of the 
alternatively spliced variant of human/3-galaetosidase (Hinek et al., 1993). 
Both antibodies were used in a concentration of 5 ttg/ml, either separately 
on adjacent serial sections or in combination. We have previously  shown 
that anti-S-GAL recognizes sheep EBP and does not cross-react with elastin 
(Hinek et al., 1993). The immune reaction was visualized with the appro- 
priate GAR or CAM secondary antibodies conjugated with 15-, 10-, or 
5-rim gold particles (as indicated in the figure legends).  Sections were then 
stained with uranyl acetate and lead citrate. In all immunostaining proce- 
dures, controls involved substitution of noulmmune ascites fluid or normal 
rabbit serum for the primary antibody. 
Immunofluorescence Microscopy 
FOr immunnfluorescent intracellular localization of the EBP and tropo- 
elastin, fetal lamb aorta SMC cultured in Medium 199 with 10% FBS for 
3 d in four-well plastic slides were washed in PBS, quickly permeabilized 
with acetone, cooled to -200C, and were then incubated in the presence 
or absence of 50 mM lactose in PBS for 15 min or 1 h. Smooth muscle cells 
were then washed in PBS,  fixed for 2 rain with 100% methanol, washed 
in PBS, blocked with 1% BSA and 5% normal goat serum in PBS, and in- 
cubated with the anti-S-GAL polyclonal  antibody recognizing EBP and 
with H1-20 monoclonal antibody to tropoelastin, both in concentrations of 
10 i~g/ml. The secondary antibodies were GAR fluorescein-cunjugated im- 
munoglobulin and rhodamine-labeled CAM antibody,  both diluted 1:100. 
As a control for studies using a monoclonal antibody,  normal ascitic fluid 
was used and, as a control for studies using a polyclonal  antibody, normal 
rabbit serum was substituted for the primary antibody. Additional  controls 
included secondary antibody alone. 
Metabolic Labeling and Immunoprecipitation 
To establish the intracelhilar relationship  between tropoelastin and the EBP, 
metabolic labeling was carried out on confluent aorta SMC cultures at pas- 
sage 2. The cells (50 ×  106/25-ml flask) were washed and preincubated in 
serum-free Medium 199 for 4 h, then labeled with [SH]valine and [3H]ser- 
ine (both 10 ~Ci/ml) in valine- and serine-free medium with 5% dialyzed 
FBS for 6 h at 370C. At the end of the pulse period, the cell layers were 
washed in PBS, scraped,  centrifuged, resuspended in 300 td of PBS with 
or without 5 ~1 of the chemical cross-linker DTSSP, vortexed,  and placed 
on ice (Nakai et al.,  1992).  After 30 rain, the DTSSP-treated  cells were 
rinsed with 2 mM glycine in PBS to block the cross-linker activity and were 
then rinsed with PBS. The cells were then lysed on ice for 15 rain with 1% 
NP-40 in 50 mM TBS, pH 8, containing proteinase inhibitors in the follow- 
ing final concentrations: 2 mM benzamidine, 2 mM EACA, 2 mM PMSF, 
1 mM EDTA, 2 mM leupeptin, and 1 mg/ml Trasylol.  After centrifugation 
at 12,000 g for 15 rain, the supernatants were precleaned by 30 rain incuba- 
tion with 50 ttl of protein A-sepharose beads,  then divided into equal ali- 
qnots that were separately  incubated with polyclonal  antibody to tropo- 
elastin and with the BCZ monoclonal antibody to bovine EBP or with 
anti-S-GAL for 1 h at 40C, and then precipitated by mixing with 50 t~l of 
protein A-Sepharose beads.  The precipitated immune complexes  were 
washed four times in 50 mM TBS, pH 8, with proteinase inhibitors and once 
with 10 mM TBS, pH 6.8. Then they were resuspended in 2  ×  Laemmli's 
sample buffer (Laemmli, 1970) containing DTT, boiled for 5 rain, and ana- 
lyzed by SDS-PAGE, followed by autoradiography and by Western immuno- 
blotting with H1-20 monoclonal antibody to tropoelastin and with anti-S- 
GAL or BCZ antibodies recognizing the 67-kD EBP (all in concentrations 
of 2 ~tg/rnl). The reactions were visualized using the peroxidase-conjugated 
goat  anti-mouse  or  peroxidase-conjugated  goat  anti-rabbit antibodies 
diluted 1:1,000 and developed with enhanced chemiluminescence detection 
kit according to the menufacturer's instruction. 
Effect of Galactosugars on Integrity of Tropoelastin 
To establish whether the EBP protects intracellular tropoelastin against pro- 
teolysis, densely plated aorta SMC (50 x  106 cells/flask) at passage 2 were 
incubated for 18 h with 15 #tCi/ml [t4C]valine in valine-free medium with 
5% dialyzed  FCS.  The cells were then scraped with a rubber policemen, 
placed on ice, rinsed weft, and quickly sonicated for 10 s in water. Cell de- 
bris was spun down by microcentrifugation (8,000 g 2 min, at 4°C), and 
the cell lysate supernatant was mixed with an equal volume of 2  ×  0.1 M 
TBS, pH 8. 100-/~1  aliquots were then incubated for 30 rain or 3 h at 37°C, 
with and without 10 mM glucosamine, 10 mM galactosamine,  20 mM lac- 
tose, or 400 ttg/rnl of chondroitin sulfate in the presence or absence of 5 
mM  EDTA,  2  mM  PMSF,  or  2  #g/mi leupeptin,  inhibitors of metal- 
loproteinases,  serine proteinases, and cysteine  proteinases, respectively. 
The lysates  were then immunoprecipitated with antitropoelastin antibody 
as described above.  The integrity of labeled imrnunoprecipitated tropo- 
elastin was established by SDS-PAGE followed by autoradiography and by 
Western blotting with the antielastin antibody as described above. 
Results 
Modification of Elastolytic Activity of Serine Elastases 
Our experiments aimed at addressing the relative specifici- 
ties  of antibodies  used  in  our  studies  showed  that anti- 
S-GAL, an antibody raised to the elastin binding-domain of 
the EBP (Hinek et al.,  1993),  also recognized serine elas- 
tases (PPE and HLE) but not elastins immobilized on PVDF 
membranes. BA-4 antibody raised to the VGVAPG sequence 
Hinek and Rabinovitch 67-kD Protein Protects Tropo and Insoluble Elastin  565 AntI-S-GAL  inhibits  elastolytic  activity  of  PPE 
% of elastolytic activity 
0  20  40  60  80  100  120 
PPE + buffer 
B  PPE  binds  to  immobilized  anti-S-GAL 
Elastolytic Activity of PPE 
Precolumn  sample 
Wash from antI-S-GAL column 
Wash from BA-4 column 
Wash from plain affi-gel 
CPM  / 1001xl sample 
o  10000 20000 30000 40000 
*  p<O.O01 
Figure 1. (A) Dot immunoblots showing that anti-S-GAL, an anti- 
body raised to the elastin-binding domain of the EBP recognizes 
PPE and HLE, but does not recognize r-elastin  or cz-elastin im- 
mobilized on PVDF membranes. BA-4 antibody raised to the VGV- 
APG sequence reflecting the receptor binding domain  of elastin 
reacts with r-elastin and c~-elastin  but not with PPE nor HLE. Con- 
trol represents the blots incubated with preimmune sera and HRP 
labeled secondary antibodies.  (B) The elastolytic activity of PPE 
assessed in precolumn samples and in the washes from the affinity 
columns made of Affi-gel immobilized anti-S-GAL and BA-4 anti- 
bodies incubated with this enzyme as described  in Materials  and 
Methods. Anti-S-GAL affinity resin but not immobilized BA-4 re- 
tained virtually all the PPE activity present in the precolumn sam- 
ples.  Radioactivity of degradation  products  (cpm/100-#l  sample) 
proteolytically released from the insoluble [3H]elastin substrate to 
the supernatants was measured in triplicate; the mean and standard 
deviations were calculated. 
reflecting the receptor-binding domain of elastin (Wrenn et 
al.,  1986) strongly reacted with x-elastin and ct-elastin, but 
not with PPE nor HLE (Fig.  1 A). Moreover, anti-S-GAL 
but not BA-4 immobilized on Atii-gel retained all elastolytic 
activity of the PPE applied to the column (Fig.  1 B). These 
results indicate that anti-S-GAL binds to PPE,  but not to 
elastin, and they further confirm the functional significance 
of the homology between the EBP and serine elastases sug- 
gested in our previous study (Hinek et al.,  1993). 
An [3H]elastin degradation assay showed that preincuba- 
tion  of PPE  with  an  anti-S-GAL  IgG that  recognizes  its 
NH2-terminal  domain  homologous  to  the  elastin-binding 
motif of the EBP precluded degradation of this substrate in 
PPE + antl-S-GAL  I 
PPE + prelmmune 
PPE + antI-C-GAL I 
*  p,O.O01 
Figure 2.  1 h preincubation of 50 ng samples of PPE with different 
concentrations  of an  anti-S-GAL  antibody  that  recognizes  its 
NH2-terminal domain homologous to the elastin-binding motif of 
the EBP precluded degradation of a 200-#g aliquot of [3H]elastin 
in a dose-dependent  manner,  presumably  by blocking binding of 
this serine proteinase to the substrate. The elastolytic activity of  the 
PPE was not affected by preincubation of the enzyme with a preim- 
mune rabbit IgG or with anti-C-GAL IgG, an antibody that recog- 
nizes  the  COOH-terminal  domain  of the  EBP, but  not its elas- 
tin-binding domain.  Radioactivity of degradation products  (cpm/ 
sample)  proteolytically  released  from insoluble  [3H]elastin sub- 
strate was measured in triplicate; the mean and standard deviations 
were  calculated.  Results  of three  separate  experiments  are  ex- 
pressed as percentages of control samples where the PPE preincu- 
bated with TBS buffer was added to radioactive elastin substrate. 
a dose-dependent manner, presumably by blocking binding 
of this serine proteinase to [aH]elastin.  The elastolytic ac- 
tivity of the PPE was not affected by preincubation of the en- 
zyme with  a  preimmune  rabbit IgG or  with  anti-C-GAL 
IgG, an antibody that recognizes the  COOH-terminal do- 
main of the EBP, but not its elastin-binding domain (Fig. 2). 
The  [3H]elastin was also protected from PPE-dependent 
degradation if the substrate was preincubated with the IgG 
fraction  of BA-4  antibody  raised  to  VGVAPG,  a  peptide 
reflecting the EBP-binding domain of elastin. Preincubation 
of the substrate with an antibody to the carboxy-terminal of 
tropoelastin (anti-C-term) did not protect it from proteoly- 
sis, presumably because it does not block the binding of the 
PPE to the elastin substrate.  An additional control showed 
that  anti-S-GAL  antibody  has  not  been  retained  by  the 
[3H]elastin substrate and that  such a  pretreatment did not 
protect  it  from  subsequent  PPE-dependent  degradation 
(Fig.  3). 
The protective effect of EBP was also observed when, be- 
fore the addition of PPE, the [3H]elastin substrate was pre- 
incubated with purified EBP or with S-GAL synthetic pep- 
tides, but not with C-GAL synthetic peptides (Fig. 4).  The 
EBP-dependent protection of the  substrate was abolished, 
however, in the presence of lactose, which prevents the as- 
sociation  of these  two  proteins.  An  additional  control  in 
which [3H]elastin preincubated with lactose alone was sub- 
jected to PPE showed the same degradation rate of the sub- 
strate as in samples preincubated with TBS buffer. This indi- 
cates  that  this  galactosugar alone  does  not  interfere  with 
direct association between elastin and PPE. 
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Figure 3. Preincubation of 200-/~g aliquots of [3H]elastin substrate 
with different concentrations of a BA-4 monoelonal antibody that 
blocks the EBP binding domain on elastin (VGV PG) protects the 
substrate from PPE-dependent degradation in a dose-dependent 
manner. Anti-C-term-IgG, an antibody to a synthetic peptide at the 
COOH-terminus of tropoelastin,  does not inhibit degradation of 
elastin by PPE (50 mg/sample) because it does not influence bind- 
ing between enzyme and substrate. Additional control shows that 
anti-S-GAL  does not bind to [3H]elastin and does not affect its 
proteolysis while preincubated with this substrate and then washed 
with TBS buffer before PPE addition. Results of three separate ex- 
periments are expressed as percentages of control samples where 
the [3H]elastin was preincubated with TBS buffer before incuba- 
tion with PPE. 
Elastin and 6 7-kD EBP Colocalize over Elastic Fibers 
and in Intracellular Compartments 
Electron microscopic immunogold labeling  using  anti-S- 
GAL demonstrated extracellular localization of  the EBP over 
elastic fibers, both in cultures of fetal lamb aorta containing 
cells actively producing elastin, as well as in aorta from adult 
sheep where active elastin synthesis is no longer taking place 
(Fig.  5,  A  and B,  respectively). Moreover, the  EBP also 
localized over elastic fibers in the auricular cartilage of adult 
sheep, suggesting that its incorporation takes place in other 
tissues where elastin is deposited (Figure 5  C). 
Double immunogold labeling of fetal lamb aorta not only 
confirmed association of elastin and the EBP over extracellu- 
lar elastic fibers, but also showed that these two proteins 
colocalize intracellularly. While we cannot be certain, the 
site of colocalization would likely be the rough endoplasmic 
reticulum and the secretory vesicles of smooth muscle ceils 
actively producing elastin (Fig. 6). 
Immunofluorescent staining of cultured aorta SMC with 
anti-S-GAL revealed a strong fibrillar pattern over the entire 
cell surface of lightly fixed and nonpermeabilized cultured 
fetal aorta SMC similar to that previously described with the 
BCZ antibody (Hinek et al.,  1991). In permeabilized cells, 
anti-S-GAL localizes to the perinuclear region. Moreover, 
the polyclonal anti-S-GAL antibody shows a pattern of intra- 
cellular localization similar  to  that  seen using  the  H1-20 
monoclonal antibody to tropoelastin (Fig. 7, A and B, respec- 
tively). The overlapping of the immunostaining with both 
antibodies detected with two different fluorescent labels was 
apparent on double-exposed microphotographs (Fig.  8 B) 
and strongly suggested intracellular colocalization of EBP 
and tropoelastin. 
EBP and S-GAL peptide protect elastin 
from PPE-dependent degradation 
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Figure 4. Binding to [3H]elastin of purified sheep EBP or of the 
synthetic S-GAL peptide reflecting the elastin binding domain of 
the spliced variant of/3-galactosidase,  but not C-GAL peptide 
reflecting the carboxy-terminal sequence of/3-galactosidase (all in 
concentration 50/zg/sarnple) protect the 200-/~g samples of  the sub- 
strate from degradation by 50-ng aliquots of PPE. The EBP does 
not protect the substrate in the presence of 100 mM lactose since 
lactose prevents association of the EBP and elastin (Hinek et el., 
1988). Lactose itself does not affect elastolytic activity of PPE. Ra- 
dioactivity of degradation products (cpm/sample) proteolytically 
released from the insoluble [3H]elastin substrate to the superna- 
tents was measured in triplicate; the mean and standard deviations 
were calculated.  Results of three  separate  experiments are  ex- 
pressed as percentages of control samples where the [3H]elastin 
was preincubated with TBS buffer before incubation with PPE. 
Permeabilized aortic SMC incubated for 15 min with 100 
mM lactose showed irregular punctate and focal distribution 
of  the EBP. This was in contrast to the nontreated cells show- 
ing condensed perinuclear immunostaining.  Permeabilized 
cells incubated for 1 h with PBS showed perinuclear local- 
ization of tropoelastin (Fig. 8 A), while in cells exposed to 
lactose, tropoelastin accumulated in dense aggregates that 
were located mostly at the cell periphery, suggesting a pro- 
cess of intracellular coacervation. (Fig.  8 C). 
Tropoelastin and EBP Form an IntraceUular Complex 
Biochemical  studies  were  next  carried  out  to  determine 
whether the intracellular colocalization of tropoelastin and 
EBP reflects complex formation. Labeling of cultured aortic 
SMC with [3H]valine and [3H]serine followed by cell lysate 
immunoprecipitation with a polyclonal antibody to tropo- 
elastin, revealed a 67-72-kD broad band of metabolically la- 
beled product that migrated on SDS-PAGE and was detected 
by  autoradiography.  Western  immunoblotting  revealed, 
however, that there was a heterogenous product reacting ei- 
ther with H1-20 monoclonal antibody to tropoelastin or with 
anti-S-GAL and BCZ antibodies, both of which recognize 
the EBP (Fig. 9 A). This suggested that tropoelastin and EBP 
may form an intracellular complex that is immunoprecipi- 
tared with antitropoelastin, but is separated by SDS-PAGE 
chromatography. This was further confirmed in experiments 
where the immunoprecipitation of proteins present in SMC 
lysates was preceded by exposure of metabolically labeled 
cells to the water-soluble chemical cross-linker DTSSP. We 
observed that both an antitropoelastin antibody, as well as 
Hinek and Rabinovitch 67-kD Protein Protects Tropo and Insoluble Elastin  567 Figure 5. Anti-S-GAL, an antibody (marked by 10-nm gold particles) recognizing the EBP, localizes exclusively to elastic fibers present 
in the extracellular matrix of fetal lamb aorta (A), and in matrices of adult sheep aorta (B) and auricular cartilage (C). Bar, 0.1 /zm. 
The Journal of Cell Biology,  Volume 126, 1994  568 Figure 6.  Representative immunoelectron micrographs with double immunogold labeling of 138-d gestation (term =  145 d) fetal lamb 
aorta demonstrating intracellular and extracellular colocalization  of tropoelastin and EBP. Anti-S-Gal recognizing 67-kD EBP is detected 
with 15-rim gold particles, while a monoclonal antibody to tropoelastin is marked with 5-nrn gold particles. Bar, 0.1 gin. (A) Tropoelastin 
and EBP colocalize in cisterna of rough endoplasmic reticulurn of a smooth muscle cell. (B) Some of the EBP also colocalizes to newly 
produced microfibrils (arrow) and in the extracellular  elastic fiber (el). (C) In culture of smooth muscle ceils (smc) from the same gestation 
aorta, the EBP colocalizes with tropoelastin intracellularly and over newly assembled ef. (D) A cell process of cultured smooth muscle 
cell is seen adjacent to a newly forming ef. Tropoelastin (5-rim) and the EBP (15-nm) appear to be secreted together and then incorporated 
into the elastic fiber (arrows), Figure  7. In permeabilized aortic SMC, double immunostaining with a fluorescein-marked  polyclonal anti-S-GAL antibody recognizing 
the 67-kD EBP (A) and with a rhodamine-labeled HI-20 monoclonal antibody to tropoelastin (B) shows similar  intracellular  localization 
of these two proteins.  Bar,  10/~m. 
Figure 8. (A) In permeabilized aortic smooth muscle cell incubated for 1 h with PBS, tropoelastin  detected with monoclonal HI-20 antibody 
followed by rhodamine conjugated GAM secondary antibody localizes mostly in perinuclear regions (ER and Golgi) and in the secretory 
vesicles.  Bar, 5/~m. (B) Double-exposed micrograph of the same cell double stained with a polyclonal anti-S-GAL and with monoclonal 
H1-20 antitropoelastin  antibody (detected  respectively  with fluorescein  and with rhodamine) show yellow-colored, overlapping  immuno- 
staining,  suggesting intracellular colocalization of EBP and tropoelastin.  (C) In permeabilized aortic smooth muscle cells  incubated  for 
1 h with 100 mM lactose, tropoelastin  localizes to dense aggregates  accumulated in the cell periphery (which suggests its intracellular 
coacervation).  Immunostaining with a  monoclonal antitropoelastin  antibody was  followed by rhodamine-conjugated GAM secondary 
antibody. 
The Journal of Cell Biology, Volume 126, 1994  570 Figure 9.  (A) A polyclonal antibody to tropoelastin precipitates a 
67-72-kD metabolically labeled product from lysates of [3H]valine 
and [3H]serine  pulsed aortic SMC as detected by SDS-PAGE fol- 
lowed by autoradiography (lane 2). Consecutive Western blotting 
with an H1-20 monoelonal antibody to tropoelastin (lane 3) and 
with anti-S-GAL and BCZ antibodies recognizing the 67-kD elastin 
binding  protein  (lanes  4  and  5,  respectively)  revealed  a  heter- 
ogenous character of this species, suggesting that tropoelastin and 
EBP form a complex that can be immunoprecipitated with the sin- 
gle antibody, lame I  shows that the control preimmune rabbit serum 
does not precipitate any of these proteins from SMC lysates. (B) 
SDS-PAGE followed by autoradiography shows that when the im- 
munoprecipitation of  proteins present in SMC lysates was preceded 
by exposure  of metabolically labeled  cells  to  the  water-soluble 
chemical cross-linker DTSSP for 15 rain (lanes 1 and 3) or for 30 
rain (lanes 2 and 4), both antitropoelastin antibody (lane 1 and 2) 
and BCZ antibody recognizing the lectin binding site of the EBP 
(lanes 3 and 4) precipitate a 140-kD species in addition to 67- and 
72-kD proteins. The longer exposure to chemical cross-linker (30 
rain)  caused  increased  accumulation of the  140-kD  species im- 
munoprecipitable with both antibodies (lanes 2 and 4). The addi- 
tional Western blot revealed that this 140-kD band also reacts with 
HI-20 monoclonal antibody to tropoelastin (lane 5) and/or with a 
polyclonal antibody to human B-galactosidase that also recognizes 
its 67-kD spliced variant and the sheep EBP (lane 6). 
the BCZ antibody that recognizes the lectin-binding  site of 
the EBP but not the S-GAL antibody, precipitated a  140-kD 
species  in  addition  to  67-  and  72-kD  proteins.  Since  the 
Western blot revealed that the  140-kD band reacted either 
with  H1-20 monoclonal  antibody  to tropoelastin  or with  a 
polyclonal  antibody  to  human  /~-galactosidase  that  also 
recognizes its 67-kD spliced variant and the sheep EBP (Hi- 
nek et al.,  1993) (Fig. 9 B), this indicates that a complex be- 
Figure 10. (A) SDS-PAGE followed by autoradiography shows that 
the SMC lysates incubated for 3 h with control buffer or with 10 
mM glucosamine (lanes I  and 2, respectively) contain the 68-72- 
kD tropoelastin (product of immunoprecipitation with a polyclonal 
antibody to tropoelastin). In contrast, the SMC lysates treated with 
10 mM galactosamine, 20 mM lactose, or 400 #g/ml of chondroitin 
sulfate (lanes 3, 4, and 5, respectively) contain multiple low molec- 
ular weight degradation products of tropoelastin, while the 68-72- 
kD tropoelastin is no longer  apparent.  (B) The SMC  lysate in- 
cubated  for  3  h  with  control  TBS  buffer containing  68-72-kD 
tropoelastin (lane 1 ). The lysate incubated with 20 mM lactose in 
the presence of 2 mM PMSF still contains the undegraded tropo- 
elastin (lane 2), while the lysates treated with 20 mM lactose in the 
presence of 0.2 % leupeptin or 5 mM EDTA (lanes 3 and 4, respec- 
tively) show the apparent tropoelastin degradation products. 
tween these two proteins was indeed formed. The presence 
of immunoprecipitated 67- and 72-kD proteins indicates that 
some of the tropoelastin  and  EBP  may not complex intra- 
cellularly. 
It is interesting to note that the anti-S-GAL antibody did 
not recognize the 140-kD complex and precipitated only the 
67-kD protein (data not shown). This probably resulted from 
the  fact  that  anti-S-GAL,  which  recognizes  the  elastin- 
binding domain of the EBP, can only bind to those EBP mol- 
ecules that are not already bound to tropoelastin.  The same 
epitope present in EBP molecules  engaged in the complex 
was  saturated  by  tropoelastin  and  was  not  accessible  to 
anti-S-GAL. 
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lntracellular Tropoelastin 
Smooth muscle cell lysates treated in the absence of pro- 
teinase  inhibitors  with  galactosugars  that  dissociated  the 
EBP-tropoelastin complex contained multiple low molecular 
weight species immunoprecipitable with the antitropoelastin 
antibody. This apparent degradation of tropoelastin was in 
contrast to the single 68-72-kD product of immunoprecipita- 
tion observed in untreated  or glucosamine-treated  lysates. 
As  assessed  by  SDS-PAGE  followed by  autoradiography, 
even a 30-rain exposure to lactose or galactosamine but not 
to glucosamine caused degradation of 68-72-kD tropoelastin 
synthesized by aortic SMC.  The 3-h exposure was usually 
sufficient for complete disappearance  of 68-72-kD  tropo- 
elastin and appearance of 52, 46, 36, 30, and 25 kD degrada- 
tion products that were precipitable with antielastin antibody 
(Fig.  10 A). Cell lysates incubated for longer time periods 
contained even smaller fragments that appeared as a smear 
below 25 kD on SDS-PAGE (data not shown). The galac- 
tosugar-induced accelerated degradation of tropoelastin was 
inhibited by addition of PMSF, but not by leupeptin or EDTA 
(Fig.  10 B). This suggested that tropoelastin released from 
its complex with the EBP is subjected to enzymatic degrada- 
tion by endogenous serine proteinase(s) present in the cell 
lysate. 
Discussion 
Recent evidence from our laboratory suggests that the 67-kD 
EBP is functionally and immunologically similar and may, 
in fact, be identical to an alternatively spliced form of B-galac- 
tosidase that has lost its catalytic activity and lysosomal tar- 
geting, but has retained its ability to bind galactosugars, and 
has acquired a frameshift generated sequence allowing it to 
bind elastin and laminin (Hinek et al.,  1993). An antibody 
(anti-S-GAL) prepared to a synthetic peptide corresponding 
to this elastin/lamirtin-binding  motif recognized the 67-kD 
EBP isolated from sheep aorta on Western blotting and had 
the same distribution of immunolocalization as the EBP on 
SMC and elastic fibers of sheep aortic tissue. We then estab- 
lished  homology  between  the  elastin/laminin-binding  se- 
quence (VVGSPSAQDEASPL) from the spliced variant of 
human/5-galactosidase and a sequence (VVGGTEAQRNS- 
WPL) from sheep EBP, as well as a sequence (VVGGTE- 
AQRNSWPS) present at the NH2-terminal of porcine pan- 
creatic elastase (Hinek et al.,  1993).  Indeed,  homologous 
sequences are also found at the NH2-terminals of a wide va- 
riety of other serine proteases, most of which do not cleave 
insoluble elastin but do, however, digest tropoelastin (Shot- 
ton and Hartley, 1970; McKenzie and White, 1991; Doolittle 
and Feng, 1987; Doolittle, 1989). This homology suggested 
that the sequence might represent a common elastin-binding 
motif on  EBP and  these  elastolytic  enzymes.  Moreover, 
since the EBP binds to the VGVAPG hydrophobic domains 
on elastin,  we speculated that  serine elastases should also 
bind to these domains. Therefore, saturation of the VGVAPG 
domains by the EBP might prevent binding of serine pro- 
teinases to tropoelastin, hence protect the substrate against 
degradation.  In the present study, we used purified EBP, a 
synthetic peptide reflecting its elastin-binding motif, and an 
antibody raised to this sequence in a series of experiments 
aimed at determining whether the EBP may bind and protect 
insoluble extracellular insoluble elastin, as well as intracel- 
lular soluble tropoelastin,  from proteolytic degradation. 
The  results  of our  experiments  showing  the  ability  of 
anti-S-GAL to bind to PPE and block the elastolytic activity 
of this serine elastase validated our hypothesis. The fact that 
the elastolytic activity of PPE was not affected by exposure 
to an antibody (anti-C-GAL) that also recognizes EBP but 
not its elastin-binding domain seems to rule out nonspecific 
IgG-mediated  interactions.  Moreover, anti-S-GAL did not 
react with immobilized soluble preparations of elastin (Fig. 
1) or with insoluble elastin (Hinek et al.,  1993). The letter 
was also confirmed by the fact that this antibody incubated 
with tritiated  elastin was easily washed away from this in- 
soluble substrate and did not prevent its subsequent PPE- 
dependent degradation  (Fig.  3). 
The proposed mechanism  of elastin-elastase  interaction 
was further  confirmed by the fact that blocking the EBP- 
binding hydrophobic VGVAPG sequence on elastin, either by 
the BA-4-specific monoclonal antibody, by purified EBP, or 
by an S-GAL synthetic peptide, appeared to prevent binding 
of active PPE to the substrate. The dose dependence of this 
phenomenon indicated that complete saturation of VGVAPG 
hydrophobic domains  on elastin  by the EBP or complete 
blocking by monoclonal antibody is necessary to fully pre- 
vent the enzyme-substrate interaction. 
Our immunomorphological studies of fetal aorta indicate 
that some of the EBP is secreted together with tropoelastin 
and  becomes  incorporated  into  fully  cross-linked  elastic 
fibers. A highly regulated process of tropoelastin molecule 
deposition onto microfibrils appears to be necessary for ap- 
propriate cross-linking of tropoelastin and assembly of the 
mature elastin fiber (Mecham and Heuser,  1991).  We have 
previously shown that either a deficiency in EBP or shedding 
of the EBP from cell surfaces by excess galactosugars dis- 
rupts assembly of elastic fibers by auricular  chondrocytes 
and vascular  SMC  (Hinek et al.,  1988,  1991;  Hinek and 
Rabinovitch,  1993).  This allowed us to speculate that the 
EBP presents tropoelastin molecules on the cell surface, and 
may  then  use  its  lectin  site  to  dock  to  a  galactosylated 
microfibrillar protein(s)  (Gibson et al.,  1989) and succes- 
sively release the bound tropoelastin onto the microfibrillar 
scaffold. 
The presence of the EBP in fully cross-linked elastic fibers 
from mature aorta and auricular cartilage suggests that this 
protein should be considered as a permanent component of 
those fibers.  Since the results of our in vitro experiments 
showed that the EBP protects insoluble elastin from enzy- 
matic degradation, one can speculate that the EBP, whether 
"trapped" by the rapidly polymerizing elastin or strategically 
located, may protect insoluble elastin from proteolysis and 
contribute to the extraordinary  stability of elastic fibers in 
vivo.  During development,  the EBP may modulate the re- 
ciprocal interaction between elastin and elastases,  control- 
ling  the  dynamic  remodeling  processes  that  regulate  the 
dimension of elastic fibers. There can be both endogenous 
vascular (Hornebeck et al.,  1975; Robert and Robert, 1980; 
Todorovich-Htmter et al.,  1992; Zhu et al.,  1993), as well 
as extravascular  sources of serine elastolytic activity.  The 
EBP  would  not,  however,  protect  insoluble  elastin  from 
metalloelastases or cysteine proteinases. 
Results of immunofluorescent  and electron microscopic 
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colocalize intracellularly  led to the suggestion that these pro- 
teins may not only coexist in the same intracellular  compart- 
ment, but may actually form a complex at an early stage in 
the secretory pathway. This assumption was confirmed by 
the fact that a polyclonal antibody to tropoelastin precipi- 
tated both EBP and tropoelastin from SMC lysates as judged 
by  immunoreactivity  on  Western  blots  with  a  monoclo- 
nal antibody to tropoelastin,  as well as with two different 
antibodies that recognize the EBP. Subsequent treatment of 
radiolabeled SMC with DTSSP, a  water-soluble chemical 
cross-linker,  followed by immunoprecipitation with an anti- 
tropoelastin or with EBP antibodies resulted in a  140-kD 
complex recognized by both antibodies.  The presence of ad- 
ditional  67- and 72-kD proteins immunoprecipitated with 
these antibodies indicates,  however, that some of the tropo- 
elastin and EBP may not complex intracellularly  and may be 
secreted in an uncomplexed form. 
Once we established that most of the EBP and tropoelastin 
form an intraceUular  complex, we were eager to elucidate 
the functional  significance  of this phenomenon. Our previ- 
ous studies  on ductus arteriosus SMC (Hinek and Rabino- 
vitch,  1993) showed that those cells, deficient in EBP, de- 
posit  little  insoluble  elastin  when  compared  with  aortic 
SMC, and they secrete an abundant soluble 52-kD truncated 
form of tropoelastin that lacks the COOH-terminal and ap- 
pears to be a product of intraceUular degradation.  We specu- 
lated that the EBP deficiency is responsible for the proteo- 
lyric intracellular degradation of tropoelastin in ductus SMC. 
The present studies confirmed that there is proteolytic degra- 
dation of the newly produced tropoelastin when there is dis- 
sociation of  the EBP from tropoelastin as a resuk of exposure 
of the SMC lysates to lactose (Hinek et al.,  1988, 1991). 
Since we showed that lactose is not itself elastolytic, and that 
it does not accelerate elastolytic activity of exogenous PPE, 
this treatment appears to allow newly produced tropoelastin 
to  become  more  accessible  to  endogenous  serine  pro- 
teinase(s) present in the lysate. Moreover, the fact that PMSF 
but not EDTA or leupeptin prevents the degradation of newly 
synthesized  tropoelastin  indicates  that  endogenous  serine 
proteinase(s) are responsible, and that intracellular  metal- 
loproteinases or cysteine proteinases do not participate  in the 
initial  stages of tropoelastin degradation. 
We also speculate that EBP-tropoelastin  complex forma- 
tion may protect tropoelastin against premature self-aggrega- 
tion (coacervation).  Because of its extreme hydrophobicity, 
tropoelastin in solution tends to undergo self-aggregation un- 
der physiological conditions (Urry et al., 1969; Volpin et al., 
1976). The maximal  coacervation of tropoelastin occurs in 
or close to its isoelectric point (Partridge  et al.,  1980), and 
modification of this protein by blockage of free amino groups 
resulting in a decrease in the isoelectric point has limited tro- 
poelastin  coacervation  in  vitro  (Podrazky  and  Jackson, 
1976). While coacervation may be an important aspect of ex- 
traceUular fiber assembly, the premature intracellular  aggre- 
gation of this protein may be detrimental and irreversibly in- 
hibit secretion of tropoelastin.  On the other hand, the EBP 
as a "companion" protein that binds and blocks the exposed 
hydrophobic VGVAGG-Iike domains on tropoelastin would 
block its final folding and ensure that aggregation  does not 
occur intracellularly  until tropoelastin is released from the 
correct site on the cell surface. 
This is in accord with the general theory of intraceUular 
chaperoning  of unfolded proteins by the heat shock proteins 
(Hsp) (Agard,  1993). The blockade of exposed hydrophobic 
patches on numerous secreted proteins requires a factor that 
can reversibly bind to them and protect against  premature 
aggregation  (Langer et al., 1992; Landry et al., 1992). The 
67-kD EBP, like Hsp-70 and its relatives, meets this require- 
ment. In the case of Hsp-70, the release of  bound protein may 
require stimulation  of endogenous ATPase,  while the EBP 
can dissociate from tropoelastin under the influence of galac- 
tosugars that bind to the lectin site of this 67-kD chaperone. 
This process would appear to unmask its elastin binding do- 
main  (S-GAL).  Our  immunofluorescent  localization  of 
tropoelastin  and EBP showed that even a brief exposure to 
lactose caused dissociation  of the intracelluiar  complex and 
led to aggregation  of tropoelastin in the cell periphery.  On 
the other hand,  we have previously shown  (Hinek et al., 
1992) that binding  of the purified EBP or S-GAL synthetic 
peptides to soluble elastin delays its temperature-dependent 
coacervation as monitored in an in vitro spectrophotometric 
assay. 
On the whole, our results suggest that the 67-kD EBP ho- 
mologous  to  alternatively  spliced  /$-galactosidase  binds 
tropoelastin  intracellularly,  escorting this highly hydropho- 
bic protein through the secretory pathways and protecting it 
from premature self-aggregation  and premature proteolytic 
degradation.  In point of fact, it may represent another molec- 
ular chaperone distinct  from the family of heat shock pro- 
teins. Moreover, some of this "companion protein 7 which is 
secreted as a  complex with tropoelastin  and mediates its 
orderly extraceUuiar assembly upon the microfibrillar  scaf- 
fold, gets incorporated as a permanent component of elastic 
fibers, which may protect the longevity of insoluble elastin. 
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